Uniphos Enterprises growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
−71.3%+120.2%+3,341.0%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+2.6%−23.6%−8.0%
+3.7%−16.6%−13.2%
+7,341.9%−99.3%−1.6%
+7,350.0%−99.3%−1.6%
−7.8%+36.8%−32.9%
−10.8%+32.1%−30.8%
−25.1%+21.6%−136.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

UNIENTER₹85.24

Uniphos Enterprises Limited

· Chemicals
₹ CrorePeersVINYLINDIASRDMcap ₹593 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—+3,341.0+120.2-71.3—
EBITDA Growth—-8.0-23.6+2.6—
EBIT Growth—-13.2-16.6+3.7—
Net Income Growth—-1.6-99.3+7,341.9—
EPS Growth—-1.6-99.3+7,350.0—
Total Assets Growth—-32.9+36.8-7.8—
Total Equity Growth—-30.8+32.1-10.8—
Cash from Operations Growth—-136.4+21.6-25.1—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.